Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.33 |
| ▸ | GNPAT | O15228 | 2/20 | 0.33 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12513863 | 0.98 | MAPT (0.46) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL1271960 | 0.94 | MAPT (0.39) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL10288381 | 0.94 | MAPT (0.39) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL31369710 | 0.86 | TGFBR1 (0.37) | MAPTABCC4ALDH1A1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2982200 | 0.85 | TGFBR1 (0.36) | MAPTABCC4ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL13494825 | 0.84 | ALDH1A1 (0.41) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL13494850 | 0.82 | ALDH1A1 (0.43) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL17400530 | 0.81 | MAPT (0.47) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL3777018 | 0.81 | GNPAT (0.49) | MAPTABCC4ALDH1A1LMNAUSP2 | |
| SCHEMBL12794390 | 0.81 | ALDH1A1 (0.50) | MAPTABCC4ALDH1A1LMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | MAPT 1809/4885ABCC4 4318/4885ALDH1A1 4472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.